Sector Update: Healthcare

08:59 AM EDT, 10/01/2026 (MT Newswires) -- Healthcare stocks were declining premarket Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.1% and the iShares Biotechnology ETF (IBB) 0.4% lower. Monte Rosa Therapeutics (GLUE) shares were up more than 4% after the company said its experimental drug, MRT-8102, achieved its phase 1 study objectives, showing strong NEK7 degradation and reductions in multiple biomarkers associated with atherosclerotic cardiovascular disease in subjects at elevated CVD risk.